Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Delayed Quote USD

Moleculin Biotech, Inc. (MBRX)

Compare
0.9610
+0.0019
+(0.20%)
At close: April 2 at 4:00:01 PM EDT
0.9610
0.00
(0.00%)
Pre-Market: 4:08:36 AM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -1.88M

Q1'24

Q2'24

Q3'24

Q4'24

-10M
-8M
-6M
-4M
-2M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

4.00
10.67 Average
0.9610 Current
20.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts ----11
Avg. Estimate 00-5.28-4.85
Low Estimate 00-5.28-4.85
High Estimate 00-5.28-4.85
Year Ago EPS -----7.81-5.28

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2232
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) 0.00%0.00%0.00%0.00%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -3.53-2.51-2.44-1.28
EPS Actual -2.02-1.7-2.85--
Difference 1.510.81-0.41--
Surprise % 42.78%32.27%-16.80%--

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 00-5.28-4.85
7 Days Ago 00-5.28-4.85
30 Days Ago 00-5.28-4.85
60 Days Ago 00-5.28-4.85
90 Days Ago 00-5.28-4.85

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days ----11
Down Last 30 Days ----11

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
MBRX ----32.41%8.14%
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Upgrade Maxim Group: Hold to Buy 3/25/2025
Reiterates HC Wainwright & Co.: Buy to Buy 3/25/2025
Reiterates HC Wainwright & Co.: Buy to Buy 3/24/2025
Maintains HC Wainwright & Co.: Buy to Buy 3/3/2025
Maintains Maxim Group: Buy to Buy 11/12/2024
Maintains Roth MKM: Buy to Buy 4/12/2024

Related Tickers